Medical Diagnostic Test Strip Manufacturing

The contract seeks the manufacture of sterile Fluorescein Sodium Ophthalmic Strips intended for corneal diagnostic applications, with strict adherence to FDA regulations, current Good Manufacturing Practices, and Defense Logistics Agency standards. The product must meet exacting quality and sterility requirements to ensure safe and effective use in clinical settings, particularly within military and government health care environments. Manufacturing must occur in compliance with all applicable regulatory frameworks, ensuring traceability, documentation integrity, and consistent batch quality throughout production. The solicitation, classified as a subcontract under NAICS code 325412, is issued by the Department of Defense through the Medical Supply Chain Pharm FSA and specifies Fort Bliss, Texas, with ZIP code 79918-2527 as the place of performance. Interested parties must submit responses by the deadline of July 28, 2026, with the opportunity to participate initiated on July 22, 2026. While no set-aside designation is specified, the procurement is managed through the DLA's DIBBS platform, indicating its alignment with federal defense supply chain protocols and requiring full compliance with all contractual and logistical expectations tied to DoD procurement practices.